Literature DB >> 35218

Electrostatic effects in hemoglobin: Bohr effect and ionic strength dependence of individual groups.

J B Matthew, G I Hanania, F R Gurd.   

Abstract

The electrostatic treatment applied in the preceding paper in this issue [Matthew, J. B., Hanania, G.I.H., & Gurd, F.R.N. (1979) Biochemistry (preceding paper in this issue)] to the titration behavior of individual groups in human deoxyhemoglobin and oxyhemoglobin was applied to the computation of the alkaline Bohr effect at various values of ionic strength. The enhanced proton binding of deoxyhemoglobin in the pH range of 6--9 was accounted for at ionic strength 0.01 M by the effects of the unique charge distributions of ionizable groups in the two quaternary states. At ionic strength 0.10 M the effects of 2--4 bound anions had to be considered in addition in the deoxyhemoglobin charge configuration. At the higher ionic strength 10 groups per tetramer contributed to the Bohr effect, whereas 28 groups were contributory at the lower ionic strength. The ionic strength dependence of individual groups in the two tetrameric structures as well as in the alpha-chain monomer was explained in terms of the electrostatic treatment. This examination showed that the differences in electrostatic behavior of deoxy- and oxyhemoglobin follow from particular dissymmetries in their configurations with respect to charge and static solvent accessibility.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35218     DOI: 10.1021/bi00577a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Probing the energetics of proteins through structural perturbation: sites of regulatory energy in human hemoglobin.

Authors:  D W Pettigrew; P H Romeo; A Tsapis; J Thillet; M L Smith; B W Turner; G K Ackers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

2.  The measurement of the intrinsic alkaline Bohr effect of various human haemoglobins by isoelectric focusing.

Authors:  C F Poyart; P Guesnon; B M Bohn
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

3.  Electrostatic stabilization in sperm whale and harbor seal myoglobins. Identification of groups primarily responsible for changes in anchoring of the A helix.

Authors:  F R Gurd; S H Friend; T M Rothgeb; R S Gurd; H Scouloudi
Journal:  Biophys J       Date:  1980-10       Impact factor: 4.033

4.  A quantitative model for the cooperative mechanism of human hemoglobin.

Authors:  M L Johnson; B W Turner; G K Ackers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Structure-specific model of hemoglobin cooperativity.

Authors:  A W Lee; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Investigation of pH-induced symmetry distortions of the prosthetic group in oxyhaemoglobin by resonance Raman scattering.

Authors:  R Schweitzer-Stenner; W Dreybrodt; D Wedekind; S el Naggar
Journal:  Eur Biophys J       Date:  1984       Impact factor: 1.733

7.  Intracellular pH during daily torpor in Peromyscus maniculatus.

Authors:  J R Nestler
Journal:  J Comp Physiol B       Date:  1990       Impact factor: 2.200

8.  Correlation of protein functional properties in the crystal and in solution: the case study of T-state hemoglobin.

Authors:  Robert W Noble; Laura D Kwiatkowski; Hilda L Hui; Stefano Bruno; Stefano Bettati; Andrea Mozzarelli
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

9.  Structure of deoxyhemoglobin Cowtown [His HC3(146) beta----Leu]: origin of the alkaline Bohr effect and electrostatic interactions in hemoglobin.

Authors:  M F Perutz; G Fermi; T B Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Site-specific semisynthetic variant of human hemoglobin.

Authors:  S A Hefta; S B Lyle; M R Busch; D E Harris; J B Matthew; F R Gurd
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.